Cargando…
Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection
BACKGROUND: A pregnant gilt infected with porcine reproductive and respiratory syndrome virus (PRRSV) can transmit the virus to her fetuses across the maternal-fetal-interface resulting in varying disease outcomes. However, the mechanisms leading to variation in fetal outcome in response to PRRSV in...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640517/ https://www.ncbi.nlm.nih.gov/pubmed/33148169 http://dx.doi.org/10.1186/s12864-020-07154-0 |
_version_ | 1783605761324089344 |
---|---|
author | Van Goor, Angelica Pasternak, Alex Walker, Kristen Hong, Linjun Malgarin, Carolina MacPhee, Daniel J. Harding, John C. S. Lunney, Joan K. |
author_facet | Van Goor, Angelica Pasternak, Alex Walker, Kristen Hong, Linjun Malgarin, Carolina MacPhee, Daniel J. Harding, John C. S. Lunney, Joan K. |
author_sort | Van Goor, Angelica |
collection | PubMed |
description | BACKGROUND: A pregnant gilt infected with porcine reproductive and respiratory syndrome virus (PRRSV) can transmit the virus to her fetuses across the maternal-fetal-interface resulting in varying disease outcomes. However, the mechanisms leading to variation in fetal outcome in response to PRRSV infection are not fully understood. Our objective was to assess targeted immune-related gene expression patterns and pathways in the placenta and fetal thymus to elucidate the molecular mechanisms involved in the resistance/tolerance and susceptibility of fetuses to PRRSV2 infection. Fetuses were grouped by preservation status and PRRS viral load (VL): mock infected control (CTRL), no virus detected (UNINF), virus detected in the placenta only with viable (PLCO-VIA) or meconium-stained fetus (PLCO-MEC), low VL with viable (LVL-VIA) or meconium-stained fetus (LVL-MEC), and high VL with viable (HVL-VIA) or meconium-stained fetus (HVL-MEC). RESULTS: The host immune response was initiated only in fetuses with detectable levels of PRRSV. No differentially expressed genes (DEG) in either the placenta or thymus were identified in UNINF, PLCO-VIA, and PLCO-MEC when compared to CTRL fetuses. Upon fetal infection, a set of core responsive IFN-inducible genes (CXCL10, IFIH1, IFIT1, IFIT3, ISG15, and MX1) were strongly upregulated in both tissues. Gene expression in the thymus is a better differentiator of fetal VL; the strong downregulation of several innate and adaptive immune pathways (e.g., B Cell Development) are indicative of HVL. Gene expression in the placenta may be a better differentiator of fetal demise than the thymus, based-on principle component analysis clustering, gene expression patterns, and dysregulation of the Apoptosis and Ubiquitination pathways. CONCLUSION: Our data supports the concept that fetal outcome in response to PRRSV2 infection is determined by fetal, and more significantly placental response, which is initiated only after fetal infection. This conceptual model represents a significant step forward in understanding the mechanisms underpinning fetal susceptibility to the virus. SUPPLEMENTARY INFORMATION: Supplementary information accompanies this paper at 10.1186/s12864-020-07154-0. |
format | Online Article Text |
id | pubmed-7640517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76405172020-11-04 Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection Van Goor, Angelica Pasternak, Alex Walker, Kristen Hong, Linjun Malgarin, Carolina MacPhee, Daniel J. Harding, John C. S. Lunney, Joan K. BMC Genomics Research Article BACKGROUND: A pregnant gilt infected with porcine reproductive and respiratory syndrome virus (PRRSV) can transmit the virus to her fetuses across the maternal-fetal-interface resulting in varying disease outcomes. However, the mechanisms leading to variation in fetal outcome in response to PRRSV infection are not fully understood. Our objective was to assess targeted immune-related gene expression patterns and pathways in the placenta and fetal thymus to elucidate the molecular mechanisms involved in the resistance/tolerance and susceptibility of fetuses to PRRSV2 infection. Fetuses were grouped by preservation status and PRRS viral load (VL): mock infected control (CTRL), no virus detected (UNINF), virus detected in the placenta only with viable (PLCO-VIA) or meconium-stained fetus (PLCO-MEC), low VL with viable (LVL-VIA) or meconium-stained fetus (LVL-MEC), and high VL with viable (HVL-VIA) or meconium-stained fetus (HVL-MEC). RESULTS: The host immune response was initiated only in fetuses with detectable levels of PRRSV. No differentially expressed genes (DEG) in either the placenta or thymus were identified in UNINF, PLCO-VIA, and PLCO-MEC when compared to CTRL fetuses. Upon fetal infection, a set of core responsive IFN-inducible genes (CXCL10, IFIH1, IFIT1, IFIT3, ISG15, and MX1) were strongly upregulated in both tissues. Gene expression in the thymus is a better differentiator of fetal VL; the strong downregulation of several innate and adaptive immune pathways (e.g., B Cell Development) are indicative of HVL. Gene expression in the placenta may be a better differentiator of fetal demise than the thymus, based-on principle component analysis clustering, gene expression patterns, and dysregulation of the Apoptosis and Ubiquitination pathways. CONCLUSION: Our data supports the concept that fetal outcome in response to PRRSV2 infection is determined by fetal, and more significantly placental response, which is initiated only after fetal infection. This conceptual model represents a significant step forward in understanding the mechanisms underpinning fetal susceptibility to the virus. SUPPLEMENTARY INFORMATION: Supplementary information accompanies this paper at 10.1186/s12864-020-07154-0. BioMed Central 2020-11-04 /pmc/articles/PMC7640517/ /pubmed/33148169 http://dx.doi.org/10.1186/s12864-020-07154-0 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Van Goor, Angelica Pasternak, Alex Walker, Kristen Hong, Linjun Malgarin, Carolina MacPhee, Daniel J. Harding, John C. S. Lunney, Joan K. Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection |
title | Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection |
title_full | Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection |
title_fullStr | Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection |
title_full_unstemmed | Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection |
title_short | Differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following PRRSV2 infection |
title_sort | differential responses in placenta and fetal thymus at 12 days post infection elucidate mechanisms of viral level and fetal compromise following prrsv2 infection |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7640517/ https://www.ncbi.nlm.nih.gov/pubmed/33148169 http://dx.doi.org/10.1186/s12864-020-07154-0 |
work_keys_str_mv | AT vangoorangelica differentialresponsesinplacentaandfetalthymusat12dayspostinfectionelucidatemechanismsofvirallevelandfetalcompromisefollowingprrsv2infection AT pasternakalex differentialresponsesinplacentaandfetalthymusat12dayspostinfectionelucidatemechanismsofvirallevelandfetalcompromisefollowingprrsv2infection AT walkerkristen differentialresponsesinplacentaandfetalthymusat12dayspostinfectionelucidatemechanismsofvirallevelandfetalcompromisefollowingprrsv2infection AT honglinjun differentialresponsesinplacentaandfetalthymusat12dayspostinfectionelucidatemechanismsofvirallevelandfetalcompromisefollowingprrsv2infection AT malgarincarolina differentialresponsesinplacentaandfetalthymusat12dayspostinfectionelucidatemechanismsofvirallevelandfetalcompromisefollowingprrsv2infection AT macpheedanielj differentialresponsesinplacentaandfetalthymusat12dayspostinfectionelucidatemechanismsofvirallevelandfetalcompromisefollowingprrsv2infection AT hardingjohncs differentialresponsesinplacentaandfetalthymusat12dayspostinfectionelucidatemechanismsofvirallevelandfetalcompromisefollowingprrsv2infection AT lunneyjoank differentialresponsesinplacentaandfetalthymusat12dayspostinfectionelucidatemechanismsofvirallevelandfetalcompromisefollowingprrsv2infection |